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863-3 Compar i son  of  Medical Treatment With Percutaneous 
Closure of Patent Foremen Ovale for Secondary 
Prevention of TIAs and Strokes: A Case-Control Study 
Staohan Windecker. Andreas Wahl, Markus Schwerzmann, Christian Seller, Krassen 
Nadeltchev, Marcel Arnold, Matthias Sturzenegger, Heinrich Mattle, Bernhard Meier, 
Swiss Cardiovascular Center Bern, Bern, Switzerland, Department of Neurology, 
University Hospital Bern, Bern, Switzerland. 
Background. Patients with transient ischemic attack (TIA) and stroke related to patent 
foremen ovale (PFO) are at risk for recurrence. The best treatment for secondary preven- 
tion is not known. The purpose of this study was to compare the risk of recurrence 
between medical treatment and percutaneous PFO closure in patients with TIA and 
stroke related to PFO. 
Methods. A total of 311 patients with TIA or stroke related to PFO were retrospectively 
included in a case-control study. 161 patients received medical treatment (oral anticoag- 
ulation: n=80, platelet inhibitors: n=81), and 150 patients underwent percutaneous PFO 
closure. The actuarial risk of recurrence was calculated and compared between the two 
groups. 
Results. The mean age of the study population was 50=13 years. The two groups were 
matched for age, sex and presence of an associated atnal septal aneurysm. The overall 
mean follow-up was 2.3¢1.8 years, 2.4±1.9 years in the medical treatment group and 
2.2¢1.5 years in the percutaneous PFO closure group. The average annual TIA and/or 
stroke rate was 6.6% in the medical and 4.5% in the endovascular group (p=0.08). There 
were no recurrent major strokes in the percutaneous PFO closure group compared with 7 
recurrent events in the medically treated patients (p=0.02). Patients with 2 or more 
events before enrolment were at higher risk for recurrence when treated medically (11% 
per year) compared to percutaneous PFO closure (5% per year; p=0.01). Multivariate 
logistic regression analysis identified arterial hypertension, and more than one ambolic 
event at baseline as significant predictors for recurrence (OR 2.2, 95% CI 1.1-4.9). 
Conclusions. Our results indicate a non-significant rend towards decreased recurrence 
for the combined endpoint of TIA and stroke, and a significant decrease in recurrent 
major strokes in patients with PFO and presumed paradoxical embolism undergoing per- 
cutaneous PFO closure compared with medical treatment. The subgroup of patients with 
2 or more events before enrolment had a significantly lower recurrence rate after percu- 
taneous PFO closure compared with medical treatment. Confirmation of these results by 
a prospective randomized trial with longer follow-up is needed. 
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863-4 Effect o f  V i tamin C on Atherosclerosis Progression and 
Cardiovascular Events in a Ten-Year Randomized Study 
(San Valentino) 
Andrew Nicolaides, Maria Rosaria Cesarone, Giovanni Belcaro. Mariateresa De Sanctis, 
Lucrezia Incandela, Maura Griffin, San Valentino Vascular Screening Project, Chieti 
University, Italy, St Mary's Hospital, Imperial College, London, United Kingdom. 
Background: subclinical carotid-femoral atherosclerotic lesions evolution and cardiovas- 
cular events in 10 years have been defined by ultrasound in a sample of 10000 sub- 
jects.Metheds: Four classes were considered (by high resolution ultrasound of the 
carotid+femoral bifurcations) at inclusion: I= normal wall; I1= wall thichening and granula- 
tion; III non-stenosing (50%) plaques. Results. In the main group the event rate in class I 
at 10 years was <1%; in II it was 8.6%; in III, 39% and in IV, 81%. A separate, compara- 
ble subgroup of 1032 subjects was randomised for Vitamin C (1g/day) and no-treatment 
to evaluate effect on cardiovascular events and on progression. When 855 subjects (444 
in the treatment group and 411 in the control group) completed the 10-year follow-up the 
analysis of the differences between the two groups indicated that in class I there were no 
differences between groups; in II there was an event rate of 3% in the Vit C group vs 8% 
in controls; in III 8% vs 38% in controls; in IV 44% vs 82% in controls (P,:0.02). Progres- 
sion (class increase) was observed in class II in 3% in the Vit C group vs 13% in controls; 
in class III in 6% vs 34% in controls and in class IV in 21% vs 67% in controls (P<0.022). 
In conclusion Vit C supplements, in a 10-year follow-up, significantly reduce the inci- 
dence of cardiovascular (including coronary) events and the progression rate of carotid- 
femoral bifurcation atheroscleretic lesions. Also the number of cardiovascular deaths is 
reduced (43% less in the Vit C group) (P<0.01). 
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863-5 The Ankle-Brachial Index: A Pred ictor  of  Cardiovascular 
Mortality. The San Valentino Vascular Screening Study 
Maria Teresa De Sanctis, Lucrezia Incandela, Maria R. Cesarene. Marco Bucci, Andrea 
Di Renzo, Maura Griffin, George Geroulakos, Mike Sabetai, Andrew N. Nicolaides, 
Antonio Barsotti, Gianni Belcaro, Chieti Universi~ San Valentino, Pescare, Italy, St 
Mary's Hospital, London, United Kingdom. 
The prognostic value of alterations in the ankle-brachial index (ABI) is not well known in 
our population. This study was conducted to know whether ABI predicts morbidity and 
mortality in a population of subjects aged > 55. METHODS. The study was planned as a 
large population study based on non-invasive vascular tests; 16.700 subjects (48% men, 
mean age 60.2, SD 6) were studied evaluating the presence of peripheral arterial dis- 
ease (PAD) and intermittent claudication (IC). RESULTS. During the 8 years (mean 5.5) 
of follow-up11.6 subjects died (2.5% of defined cardiac causes; 0.92% suddenly). 
According to the Rotterdam study model, compared to subjects with ABI>0.9 and no IC: 
a) subjects with IC and ABI < 0.9 had an age and sex adjusted increased risk of 2.2 for all 
causes mortality (hazard ratio = HR 2.1, 95% Conf Int = CI 1.3-3.2); b)subjects with 
ABI<09 and non IC had a risk of 1.5% (HR 1.5, 95% CI 1.2-2.0); c) subjects with ABI> 
0,9 and IC had a risk of 1.4 (HR 1.3, 95% CI 0.5-3.3) not significantly different from those 
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with ABI> 0.9 without IC. Additional adjustements for the presence of stroke, myocardial 
infarction, diabetes, hypelipidemia, smoking at baseline slightly reduced the risk. The 
same pattern was observed for the risk of cardiovascular mortality. CONCLUSIONS. ABI 
is an important predictor of cardiovascular and all-cause mortality and cardiovascular 
events. Our results, in a different population, are comparable to data from the Rotterdam 
Study and therefore ABI value is comparable in different population/countries. 
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863-6 Secular Trends and Long-Term Survival in 
ThromboangiiUs Obliterans 
Tak-Sun Tee. Robert D. McBane, Anthony W. Stanson, Karla V. Ballman, Michael A. 
Mikhail, Leslie T. Cooper, Mayo Clinic and Foundation, Rochester, Minnesota. 
Background: Thromboangiitis obliterans (TAO) is an unusual disorder of medium and 
small arteries. Secular trends and long term prognosis in TAO have not been described. 
Methods: We reviewed the medical records of all TAO patients (n=343) registered at 
Mayo Clinic from 1/1/1976 to 12/31/1999. The inclusion criteda were: Age >50, tobacco 
use, objective evidence of medium or small arterial disease (angiography 45%, biopsy 
11%, noninvasive tests 44%), and no other cause. 108 patients were excluded. Results: 
The mean age of the 235 TAO patients was 33.5 :~ 8.5 yrs. The percentage of female 
patients increased from 1976 to 2000 (Table, p=.003 for trend).Four patients had a family 
history of TAO and 120(51%) had a family history of cardiovascular disease. 153 (65%) 
patients presented with intermittent claudication, 170 (73%) had rest pain, 92 (39%) 
patients had Raynauds phenomenon, and 82 (35%) had superficial thrombophlebitis. 
Ischemic ulceration or gangrene was present in 164 (70%). By Kaplan-Meier analysis the 
rate of any amputation was 61.5% at 17 years. The rate of amputation per person year 
was similar before and after 1990 (.077 vs .087). 5.1% of TAO patients died during fol- 
low-up. Conclusions: These data suggest that the percentage of women diagnosed with 
TAO is increasing. The rate of amputation in the past decade remains high despite 
advances in medical therapy; nontheless, the mortality rate is low at 5.1%. 
Gender by Year of Onset of TAO 
Year of Onset 
Gender 1976-80 1981-85 1986-90 1991-95 1996-99 Total 
Female 6(15.8%) 11(26.8%) 18(40.9%) 15(50.0%) 4(36.4%) 54(32.9%) 
Male 32(84.2%) 30(73.2%) 26(59.1%) 15(50.0%) 7(63.6%) 110(67.1%) 
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1199-69 Act ivat ion  of  Tol l - l ike Receptor  4 in Advent i t ia l  Cel ls  by 
Lipopolyseccharide Induces Neointima Formation In • 
Mouse Model 
Arvan Vink. Jelger J. van der Meer, Ben van Middelaar, Paul H. Quax, Cornelius Borer, 
Gerard Pastarkamp, Dominique P. de Kleijn, University Medical Center, Utrecht, The 
Netherlands, TNO-PG, Leiden, The Netherlands: 
Background: Previously, we demonstrated that the gram negative bacterium Chlamydia 
pneumoniae is frequently present in the adventitia of atheresclerotic coronary arteries. 
The toll-like receptor 4 (TLR4) is identified as the transmembrane receptor of 
lipopolysacchadde (LPS) and heat shock protein 60, which are both components of 
Ch/amydia pneumoniae. We recently demonstrated that the TLR4 is expressed in adven- 
titial fibroblasts. Activation of this receptor induced the release of chemokines and other 
cytokines, like IL-6. The aim of the present study was to determine whether activation of 
the TLR4 in the adventitia by LPS induces neointima formation in an in vivo situation. 
Methods: BALB/C mice were used. In 18 mice, a non-constrictive polyethylene cuff (ID 
4mm, OD 8ram) was placed loosely around the right femoral artery. In 9 control mice 2% 
gelatin was injected in the peri-edventitial space between the cuff and the artery. In the 
other 9 mice 2% gelatin with LPS (4 I~g) was injected between cuff and artery. The mice 
were sacrificed after 3 weeks. 
Results: The intimal area in the LPS treated group was significantly larger compared to 
the controls (9138 +_ 5143 versus 2353 + 3228 ~m 2, respectively, p=0.003). Intima to 
media ratio was larger in the LPS treated group compared to the controls (0.95 +_ 0.51 
versus 0.23 ¢ 0.27, respectively, p=0.O02). 
Conclusion: Adventitial lipopolysaccharide application augmented neointimal formation 
induced by a cuff. This result implies that activation of adventitial cells via toll-like recep- 
tor 4 might participate in arterial obstructive diseases. 
